Cargando…
Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
AIM: This study aims to investigate any modification of serological FSCN1 in prostate cancer patients compared with patients without neoplasia. MATERIAL & METHODS: Clinical data and blood specimens from patients with and without prostate cancer were obtained. A quantitative sandwich ELISA method...
Autores principales: | Tătaru, Octavian Sabin, Martha, Orsolya, Crocetto, Felice, Barone, Biagio, Voidazan, Septimiu, Borda, Angela, Sin, Anca, Hutanu, Adina, Loghin, Andrada, Sin, Ileana, Porav-Hodade, Daniel, Chibelean, Calin Bogdan, Vartolomei, Liliana, Lucarelli, Giuseppe, Ferro, Matteo, Osan, Virgil Gheorghe, Buonerba, Carlo, Vartolomei, Mihai Dorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558850/ https://www.ncbi.nlm.nih.gov/pubmed/34737886 http://dx.doi.org/10.2144/fsoa-2021-0051 |
Ejemplares similares
-
Fascin is secreted in male's serum: results of a pilot study
por: Porav-Hodade, Daniel, et al.
Publicado: (2018) -
Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
por: Balan, Daniel, et al.
Publicado: (2018) -
Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer
por: Balan, Daniel, et al.
Publicado: (2021) -
PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy
por: Nechifor-Boilă, Ioan Alin, et al.
Publicado: (2021) -
The Role of Biomarkers and Scores in Describing Urosepsis
por: Guliciuc, Mădălin, et al.
Publicado: (2023)